HopeStage
Back to all studies
CompletedNCT04209296

Review of Patient Records After Ketamine Infusions

About this titleRead the official source — NCT04209296
Observational studyAges 18–65CanadaDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
MississaugaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 3, 2019
Recruitment status
Completed
Enrollment listed in the registry
891
Sponsor
Brain and Cognition Discovery Foundation
Sponsor type
Non-profit organization
Study type
Observational
Intervention type
Drug
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT04209296
Official title
Show the full official title

A Retrospective Chart Review of Patients Undergoing Ketamine Infusions at the Canadian Rapid Treatment Center of Excellence

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Mississauga

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brain and Cognition Discovery Foundation.

Did this study involve medication?

Yes. The study involved medication, including Ketamine Hydrochloride.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies